Page 115 - GPD-4-1
P. 115

Gene & Protein in Disease                                        Prognostic role of SIRT1 expression in cancer




            Table 3. Subgroup analyses of various variables included in the study
            Subgroup        No. of studies  Summary effect size  95% confidence   Sig. (2‑tailed)  Overall P-value  Z‑value  I  statistics
                                                                                                     2
                                                          interval
                                                       Lower  Upper
            Geographical region
             Asia               10          1.319      0.608  2.029    <0.001       0.00      3.638   0.0001
             Non-Asia            5          1.819       0.8   2.839    <0.001       0.00      3.498   0.0001
             China               5          1.428      0.415  2.441    0.006        0.01      2.763   0.0000
            Sample size
             Small (<100)        8          1.357      0.535   2.18    0.001        0.00      3.234   0.0001
             Medium (101 – 500)  5          1.553      0.556   2.55    0.002        0.00      3.053   0.0001
             Large (>500)        2          1.731      0.255  3.207    0.021        0.02      2.299   0.0000
            Cancer type
             Ovarian cancer      3          1.369      0.056  2.682    0.041        0.04      2.043   0.0001
             Uterine cancer      2          1.712      −0.01  3.434    0.051        0.05      1.949   0.0001
             Renal cell carcinoma  2        1.458      −0.065  2.98    0.061        0.06      1.876   0.0000
             Lung cancer         3          1.548      0.191  2.905    0.025        0.03      2.236   0.0001
             Gastric cancer      2          1.767      0.222  3.313    0.025        0.03      2.241   0.0001
             Breast cancer       1           1.31      −0.787  3.407   0.221        N/A       1.224    N/A
             Colorectal cancer   2          1.195      −0.376  2.766   0.136        0.14      1.491   0.0001
            Age group
             50 – 55=1           2          1.095      −0.434  2.624   0.161        0.16      1.403   0.0000
             56 – 60=2           6           1.63      0.695  2.565    <0.001       0.00      3.416   0.0001
             61 – 65=3           3          1.607      0.244  2.969    0.021        0.02      2.311   0.0001
             66 – 70=4           1           1.42      −0.932  3.772   0.237        N/A       1.183    N/A
            Sex
             Male                9          1.498      0.752  2.244    <0.001       0.00      3.937   0.0001
             Female              6          1.458      0.524  2.393    0.002        0.00      3.058   0.0001
            Tumor stage
             I–IV                6          1.717      0.773  2.662    <0.001       0.00      3.563   0.0000
             I–III & IV          3          1.647      0.345   2.95    0.013        0.01      2.479   0.0001
             I–III               2          1.012      −0.53  2.553    0.198        0.2       1.287   0.0001
             III–IV              1           1.1       −1.134  3.334   0.335        N/A       0.965    N/A
             I                   1           1.31      −0.905  3.525   0.246        N/A       1.159    N/A
             III                 1           1.42      −0.932  3.772   0.237        N/A       1.183    N/A
            SIRT1 expression level
             Low                 5          1.243      0.286  2.199    0.011        0.01      2.547   0.0001
             High               10          1.624      0.889   2.36    <0.001       0.00      4.329   0.0000
            Note: N/A: Not applicable for single-study analysis.
            Abbreviations: No.: Number; Sig.: Significance.

            results  within  each  subgroup, indicating  robust  findings   trim-and-fill analysis provided no significant evidence
            across different variables in the current study.   of publication bias in the present study (Egger’s test:
                                                               P = 0.752; trim-and-fill analysis: P < 0.001). However, the
            3.4. Publication bias                              aggregation of primary studies at the base of the funnel plot
            Despite  concerns  raised  by  the  absence  of  heterogeneity   and the asymmetry in the bubble plot (Figure 4A and B)
            in the overall meta-analysis, both Egger’s test and the   may raise concerns. Consequently, the non-significant


            Volume 4 Issue 1 (2025)                         7                               doi: 10.36922/gpd.4294
   110   111   112   113   114   115   116   117   118   119   120